Gleam Up Jwel Limiteed (542477)
Slow GrowerScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹2.84 |
| Market Cap | ₹13.57 Cr |
| P/E Ratio | 678.5 |
| ROCE | 0.13% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 33.33% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹10.14 — ₹16.45 |
| Sector | Commercial Services & Supplies |
Strengths
- Piotroski F-Score of 6/9 indicates some accounting health, with no obvious red flags in reported ratios.
- Latest quarter revenue of ₹8 crore shows the trading operation is alive and generating some sales.
- Profit growth of 33.33%, while low-base, at least points in the right direction.
- Small ₹14 crore market cap means even a small absolute improvement can move the stock if business fundamentals improve.
Concerns
- P/E of 678.50 and PEG of 20.36 are absurd for a business with 0% sales growth and near-zero profitability.
- ROCE of 0.13% indicates the company is earning almost nothing on the capital it employs.
- No promoter holding, book value, debt/equity, or dividend data leaves investors unable to assess governance or asset backing.
- The current price of ₹2.84 is outside the stated 52-week range of ₹10.14-₹16.45, suggesting either bad data or a broken/illiquid tape.
AI Analysis
Let me apply the Graham-Buffett test. First, what is the business worth? The market capitalisation is ₹14 crore, but the P/E is 678.50. That means I am paying almost seven hundred years of current earnings for a trading and distribution company. Second, what does it earn on capital? ROCE is 0.13% — the capital employed is producing almost nothing. Sales growth is 0.00%, and the latest quarter shows sales of ₹8 crore and net profit of roughly ₹0 crore. The reported profit growth of 33.33% is a mirage because the base is negligible. Third, who runs it and are they honest? No promoter holding is disclosed. No book value, no debt-equity ratio, no dividend. Graham demanded a margin of safety; with so much missing data, there is no margin of safety. Even the price data fails the sanity check: the stated 52-week range is ₹10.14 to ₹16.45, yet the current price is ₹2.84. That is impossible for a valid range, so I cannot trust anything else. The Piotroski score of 6/9 is the only positive, but accounting cleanliness on a microcap with zero economic return is not a reason to invest. A PEG of 20.36 tells every honest analyst that the market is pricing in growth that has not appeared. In India, retail investors often mistake a falling price for a bargain. This is not a bargain; it is a low-return, no-growth, no-disclosure microcap. No moat, no pricing power, no earnings power. In Buffett's words, it is better to be approximately right than precisely wrong. The precise answer here is that this business is unanalysable at this price. I will keep my capital and wait for a better curve ball to hit.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer